COMMUNIQUÉS West-GlobeNewswire

Tetraphase Pharmaceuticals Announces Everest Medicines’ Submission of an Investigational New Drug Application for Eravacycline in Complicated Intra-Abdominal Infection to the China Food and Drug Administration
04/06/2018
WATERTOWN, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals
04/06/2018
RANCHO CUCAMONGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]
Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting
04/06/2018
MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe [...]
Chi-Med Presents Further Fruquintinib FRESCO Trial Data at ASCO 2018 Annual Meeting
04/06/2018
– Chi-Med makes additional FRESCO presentations at ASCO 2018, following oral presentation at ASCO 2017 showing that study met all endpoints with a manageable safety profile and lower off-target toxicities compared to [...]
Canada Health’s System Leaders Gather to Drive Improvement in Key Health Issues on June 4th and 5th, 2018 in St. John’s, NL
04/06/2018
ST. JOHN's, Newfoundland, June 04, 2018 (GLOBE NEWSWIRE) -- More than 700 health leaders, health policy experts and trustees will convene in St. John’s for the National Health Leadership Conference (NHLC) on June 4 th [...]
Terveystalo Plc: Managers' transactions - Von Rettig
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:45 EEST ____________________________________________ Person subject to the notification requirement Name: Von Rettig, Tomas Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Viippola
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:40 EEST ____________________________________________ Person subject to the notification requirement Name: Viippola, Katri Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Michelet
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:35 EEST ____________________________________________ Person subject to the notification requirement Name: Michelet, Åse Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Holmström
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:30 EEST ____________________________________________ Person subject to the notification requirement Name: Holmström, Olli Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Heinonen
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:25 EEST ____________________________________________ Person subject to the notification requirement Name: Heinonen, Lasse Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Cappelen
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:20 EEST ____________________________________________ Person subject to the notification requirement Name: Cappelen, Ulf Position: Member of the Board/Deputy [...]
Terveystalo Plc: Managers' transactions - Ahdekivi
04/06/2018
Terveystalo Plc, Managers' transactions, 4 June 2018 at 10:15 EEST ____________________________________________ Person subject to the notification requirement Name: Ahdekivi, Eeva Position: Member of the Board/Deputy [...]
PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer
04/06/2018
PHILADELPHIA and OXFORD, United Kingdom, June 04, 2018 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd . (PsiOxus), a leader in gene therapy for cancer, today announced the appointment of Melissa Epperly as Chief [...]
ViroGates publishes prospectus for its initial public offering in Copenhagen
04/06/2018
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. This announcement does not constitute a prospectus. No one [...]
Transactions under Novozymes’ stock buyback program
04/06/2018
Please read the full announcement in the attached PDF Attachment 2018_37_Stock_Buybackprogram_EN
New phantom share-based incentive program
04/06/2018
Orphazyme A/S Company announcement No. 07/2018 Copenhagen, June 4, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the [...]
Shire plc : Rule 2.9 Announcement
04/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 June 2018 Shire [...]
CMR Surgical raises $100 million in a Series B financing
04/06/2018
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical raises $100 million in a Series B financing Europe’s largest medical device financing paves way to Versius ® commercialisation Cambridge, UK, 4 June [...]
ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018
04/06/2018
LYON, France, June 04, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances [...]

Pages